BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22785429)

  • 1. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
    Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
    Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
    Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
    J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
    McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer.
    Zhang X; Zhang X; Chang Z; Wu C; Guo H
    J BUON; 2018; 23(5):1467-1471. PubMed ID: 30570874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
    Zafón C; Obiols G; Mesa J
    Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
    Kim H; Jung J; Cho YS; Choi JY; Park H; Lee YB; Kim SW; Chung JH; Kim TH
    Sci Rep; 2021 Nov; 11(1):22322. PubMed ID: 34785735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.
    Polyzos SA; Kita M; Efstathiadou Z; Poulakos P; Slavakis A; Sofianou D; Flaris N; Leontsini M; Kourtis A; Avramidis A
    J Cancer Res Clin Oncol; 2008 Sep; 134(9):953-60. PubMed ID: 18327610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Function Reference Values in Healthy Iodine-Sufficient Pregnant Women and Influence of Thyroid Nodules on Thyrotropin and Free Thyroxine Values.
    Ollero MD; Toni M; Pineda JJ; Martínez JP; Espada M; Anda E
    Thyroid; 2019 Mar; 29(3):421-429. PubMed ID: 30693851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.
    Kim SS; Lee BJ; Lee JC; Song SH; Kim BH; Son SM; Kim IJ; Kim YK; Kang YH
    Endocrine; 2011 Jun; 39(3):259-65. PubMed ID: 21161440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.
    Boi F; Minerba L; Lai ML; Marziani B; Figus B; Spanu F; Borghero A; Mariotti S
    J Endocrinol Invest; 2013 May; 36(5):313-20. PubMed ID: 22931861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
    Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
    Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
    Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
    Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Serum Thyrotropin Concentrations within the Reference Range: A Predictor of Malignancy in Nodular Thyroid Disease.
    Duccini K; de Souza MVL; Delfim R; Aguiar AP; Teixeira P; Vaisman M
    Med Princ Pract; 2018; 27(3):272-277. PubMed ID: 29514150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
    Su A; Zhao W; Wu W; Wei T; Ruan M; Li Z; Zhu J
    Am J Surg; 2020 Sep; 220(3):634-641. PubMed ID: 31955813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
    Swan KZ; Nielsen VE; Godballe C; Thrane JF; Mortensen MR; Schytte S; Pedersen HB; Christiansen P; Bonnema SJ
    Endocrine; 2018 Aug; 61(2):308-316. PubMed ID: 29855783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology.
    Adhami M; Michail P; Rao A; Bhatt CR; Grodski S; Serpell JW; Lee JC
    World J Surg; 2020 Feb; 44(2):363-370. PubMed ID: 31502005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thyrotropin concentration in children with isolated thyroid nodules.
    Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
    J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between the serum TSH concentration and thyroid cancer incidence].
    Li JZ; Jin YJ; Liu X; Zhang LY
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
    Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
    Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.